Generative AI has come for behavioral health. Now the question is this: What will the industry do about it? Forward-thinking and innovative approaches to technology may help the behavioral health industry tackle some of its most pressing challenges. Further, early adoption may allow the industry to play a meaningful role in generative AIs development and […]
With macroeconomic headwinds leading to declining valuations and less M&A activity, the mental health space is at a crossroads. The notoriously fragmented industry is still prime for maturation, but many companies are facing growing pains. Several companies that came onto the public market during the 2021 boom year are struggling to keep up with investor […]
The new telehealth restrictions proposed by the Drug Enforcement Administration (DEA) last week struck a sour chord with several industry stakeholders. Many industry insiders condemned the move as out of touch and even dangerous, jeopardizing telehealth models’ effectiveness in behavioral health. Still, the proposal is not set in stone, and parts of it could change […]
Digital health unicorn Cerebral has quietly begun to close its medication-assisted treatment (MAT) program for opioid use disorder (OUD). This comes as the Drug Enforcement Administration (DEA) on Friday announced a new proposal that would allow providers to prescribe buprenorphine for treating OUD for 30 days but then require an in-person exam. This could have […]
The year 2022 saw several growing pains and tough lessons in the behavioral health industry. Two years after the onset of a world-altering pandemic, the behavioral health industry saw adjustments and reactions to a lot of new developments. The industry did so while grappling with several of its chronic headaches such as workforce shortages and […]
The Drug Enforcement Administration is going after TruePill — the online pharmacy partner of Cerebral — for alleged inappropriate prescribing practices of controlled substances, specifically for the ADHD medication Adderall. On Friday, the federal agency announced that it started the administrative process of revoking TruePill’s license to prescribe controlled substances. The DEA alleges that TruePill […]
Cerebral Inc. has taken legal action to collect on a $50 million loan it made to Co-Founder and former CEO Kyle Robertson. The behavioral health tech company asked a state judge in New York to order Robertson to pay $25.4 million of a $49.8 million promissory note. Cerebral issued Robertson the loan in January to […]
Cerebral Inc. may be headed for a legal battle with former CEO Kyle Robertson, one of the co-founders of the mental health company. Robertson stopped being Cerebral’s CEO in May, when he was replaced by Chief Medical Officer Dr. David Mou. On Friday, a source told Behavioral Health Business that Robertson has sent a letter […]
The leaders of Cerebral Inc. reportedly told employees that the company grew too fast and that it’s now pulling back on growth to get onto a sustainable trajectory. On Monday, top executives of Cerebral — including President Jessica Muse and CEO David Mou — held town hall meetings with employees as part of the communication […]
Cerebral Inc. announced to employees it will lay off 20% of its workforce, impacting just over 1,000 people. This news, which was first reported by The Wall Street Journal, marks the second major round of layoffs announced by the company this year. In June, the San Francisco-based digital mental health startup confirmed it would institute […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
